UA95911C2 - Производные хинолина как антибактериальные средства - Google Patents

Производные хинолина как антибактериальные средства

Info

Publication number
UA95911C2
UA95911C2 UAA200800827A UAA200800827A UA95911C2 UA 95911 C2 UA95911 C2 UA 95911C2 UA A200800827 A UAA200800827 A UA A200800827A UA A200800827 A UAA200800827 A UA A200800827A UA 95911 C2 UA95911 C2 UA 95911C2
Authority
UA
Ukraine
Prior art keywords
alkyl
het
ris
ris hydrogen
alkyloxy
Prior art date
Application number
UAA200800827A
Other languages
English (en)
Ukrainian (uk)
Inventor
Коенраад Джозеф Лодевжик Марсель Андриес
Анил Коул
Жером Эмиль Джорж Жильмонт
Элизабет Тереса Джианн Пасквер
Original Assignee
Янссен Фармацевтика Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35768115&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA95911(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Янссен Фармацевтика Н.В. filed Critical Янссен Фармацевтика Н.В.
Publication of UA95911C2 publication Critical patent/UA95911C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
UAA200800827A 2005-08-03 2006-07-31 Производные хинолина как антибактериальные средства UA95911C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05107155 2005-08-03

Publications (1)

Publication Number Publication Date
UA95911C2 true UA95911C2 (ru) 2011-09-26

Family

ID=35768115

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200800827A UA95911C2 (ru) 2005-08-03 2006-07-31 Производные хинолина как антибактериальные средства

Country Status (31)

Country Link
US (1) US8691800B2 (ru)
EP (1) EP1912649B1 (ru)
JP (1) JP5208739B2 (ru)
KR (1) KR101413094B1 (ru)
CN (1) CN101277698B (ru)
AP (1) AP2483A (ru)
AR (1) AR054888A1 (ru)
AU (1) AU2006274873B2 (ru)
BR (1) BRPI0614099B8 (ru)
CA (1) CA2615900C (ru)
CY (1) CY1113535T1 (ru)
DK (1) DK1912649T3 (ru)
EA (1) EA014834B1 (ru)
ES (1) ES2397358T3 (ru)
HK (1) HK1124232A1 (ru)
HR (1) HRP20120910T1 (ru)
IL (1) IL189140A (ru)
JO (1) JO2837B1 (ru)
ME (1) ME01485B (ru)
MX (1) MX2008001601A (ru)
MY (1) MY147637A (ru)
NO (1) NO342328B1 (ru)
NZ (1) NZ566012A (ru)
PL (1) PL1912649T3 (ru)
PT (1) PT1912649E (ru)
RS (1) RS52606B (ru)
SI (1) SI1912649T1 (ru)
TW (1) TWI385168B (ru)
UA (1) UA95911C2 (ru)
WO (1) WO2007014934A2 (ru)
ZA (1) ZA200801106B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2837B1 (en) 2005-08-03 2014-09-15 جانسن فارمسيتكا ان في Quinoline derivatives acting as antibacterial agents
JO2683B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO3271B1 (ar) * 2006-12-06 2018-09-16 Janssen Pharmaceutica Nv مشتقات الكوينولين المضادة للجراثيم
JP5246715B2 (ja) 2009-01-27 2013-07-24 独立行政法人科学技術振興機構 蛋白質架橋阻害剤およびその用途
PL2841425T3 (pl) 2012-04-27 2016-10-31 Antybakteryjne pochodne chinoliny
EA038350B1 (ru) 2012-04-27 2021-08-12 Янссен Фармацевтика Нв Антибактериальные хинолиновые производные
EP4148053A1 (en) * 2016-03-07 2023-03-15 The Global Alliance for TB Drug Development, Inc. Antibacterial compounds and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965572A (en) * 1996-10-28 1999-10-12 The United States Of America As Respresented By The Secretary Of The Army Methods for treating antibiotic-resistant infections
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
GB0101577D0 (en) * 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
AR040336A1 (es) * 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
NZ538391A (en) * 2002-07-25 2005-10-28 Janssen Pharmaceutica Nv Quinoline derivatives and their use as mycobacterial inhibitors
US7338949B2 (en) * 2004-01-23 2008-03-04 Janssen Pharmaceutica N.V. Mycobacterial inhibitors
JO2837B1 (en) 2005-08-03 2014-09-15 جانسن فارمسيتكا ان في Quinoline derivatives acting as antibacterial agents

Also Published As

Publication number Publication date
JO2837B1 (en) 2014-09-15
BRPI0614099A2 (pt) 2011-03-09
BRPI0614099B8 (pt) 2021-05-25
EP1912649B1 (en) 2012-10-10
CY1113535T1 (el) 2016-06-22
CA2615900C (en) 2014-12-09
WO2007014934A8 (en) 2007-05-18
BRPI0614099B1 (pt) 2019-11-12
EA200800513A1 (ru) 2008-06-30
KR101413094B1 (ko) 2014-07-01
WO2007014934A2 (en) 2007-02-08
TW200800971A (en) 2008-01-01
PT1912649E (pt) 2013-01-14
NO20081068L (no) 2008-02-29
NZ566012A (en) 2011-02-25
TWI385168B (zh) 2013-02-11
WO2007014934A3 (en) 2007-04-05
AR054888A1 (es) 2007-07-25
IL189140A (en) 2014-07-31
CA2615900A1 (en) 2007-02-08
US8691800B2 (en) 2014-04-08
SI1912649T1 (sl) 2013-01-31
HK1124232A1 (en) 2009-07-10
PL1912649T3 (pl) 2013-03-29
US20080227775A1 (en) 2008-09-18
JP5208739B2 (ja) 2013-06-12
KR20080039961A (ko) 2008-05-07
AP2483A (en) 2012-10-01
RS52606B (en) 2013-04-30
ES2397358T3 (es) 2013-03-06
MX2008001601A (es) 2008-02-19
JP2009503021A (ja) 2009-01-29
CN101277698A (zh) 2008-10-01
IL189140A0 (en) 2008-08-07
DK1912649T3 (da) 2013-01-21
AU2006274873B2 (en) 2012-12-13
EA014834B1 (ru) 2011-02-28
HRP20120910T1 (hr) 2012-12-31
ZA200801106B (en) 2009-09-30
MY147637A (en) 2012-12-31
CN101277698B (zh) 2011-06-22
AU2006274873A1 (en) 2007-02-08
EP1912649A2 (en) 2008-04-23
ME01485B (me) 2014-04-20
NO342328B1 (no) 2018-05-07

Similar Documents

Publication Publication Date Title
UA95916C2 (ru) Производные хинолина как антибактериальные средства
UA95915C2 (ru) Производные хинолина как антибактериальные средства
TW200637551A (en) Treatment of latent tuberculosis
UA95911C2 (ru) Производные хинолина как антибактериальные средства
WO2005070924A8 (en) Substituted quinolines and their use as mycobacterial inhibitors
MY173664A (en) Quinoline derivatives as antibacterial agents
UA92175C2 (ru) Производные хинолина как антибактериальные агенты
MY151030A (en) Quinoline derivatives as antibacterial agents
JO2695B1 (en) Treatment of latent TB